GlassScriptPhysician profile
Ryan Anthony Martinez
NPI 1043623184
$1,133.65
in general payments reported to CMS, 2019-2025
18 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.75 · 2020: $95.43 · 2021: $35.51 · 2022: $74.69 · 2023: $133 · 2024: $427 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $198.22 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $163.48 | 2019-2025 | Evenity, Prolia, Repatha |
| Ibsa Pharma INC. | $162.96 | 2020-2024 | Tirosint, Tirosint, Flector |
| Glaxosmithkline, LLC. | $134.53 | 2024-2025 | Shingrix, Trelegy Ellipta |
| Pfizer INC. | $127.46 | 2019-2024 | |
| Dexcom, INC. | $61.11 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $49.95 | 2024-2025 | Airsupra, Farxiga |
| Merck Sharp & Dohme LLC | $35.47 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Abbvie INC. | $30.60 | 2024 | |
| Edwards Lifesciences Corporation | $30.30 | 2025 | Sapien 3 Ultra Resilia |
| Exact Sciences Corporation | $29.75 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $19.33 | 2025 | Mounjaro |
| Novo Nordisk INC | $18.45 | 2024 | Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $18.23 | 2023 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $17.27 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $13.68 | 2024 | |
| Ge Healthcare | $11.75 | 2019 | |
| Lupin INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.